Charlotte, NC; April 5, 2012 — DecisionPoint is proud to announce that Andy Agrawal, one of its Managing Partners, advised MCN BioProducts Inc. ("MCN") on its recently announced transaction with Bunge Limited (NYSE: BG) ("Bunge"). The assets Bunge acquired from MCN include intellectual property related to the conversion of canola and rapeseed meals into nutritionally dense protein concentrates that can replace both fishmeal and vegetable protein concentrates in animal diets, including aquaculture.
While the transaction was completed under the auspices of Agrawal's prior firm, according to Todd Lahti, MCN's CEO, "Andy was critical to completing this transaction. His ability to build relationships, manage deal issues and develop creative solutions made this transaction possible."
A copy of Bunge's press release announcing the deal may be found at:
About MCN BioProducts Inc.
MCN BioProducts Inc. ("MCN" or the "Company") is a technology company focused on unlocking the value of Canola (or rapeseed) meal, one of the world's highest quality plant-based protein sources for use in agricultural feed, food products, cosmetics and industrial markets. Founded in 2000 and headquartered in Saskatoon, Canada, MCN developed a patented process that enhances the nutritional potential of canola meal, which the Company believes will create significant value for the canola industry. The Company's lead technology has been peer reviewed, successfully tested in multiple pilot scale production facilities, and is now undergoing full-scale commercialization.
About Bunge Limited
Bunge Limited (NYSE: BG) is a leading global agribusiness and food company with approximately 32,000 employees in more than 30 countries. Bunge buys, sells, stores and transports oilseeds and grains to serve customers worldwide; processes oilseeds to make protein meal for animal feed and edible oil products for commercial customers and consumers; produces sugar and ethanol from sugarcane; mills wheat and corn to make ingredients used by food companies; and sells fertilizer in North and South America. Founded in 1818, the company is headquartered in White Plains, New York.
DecisionPoint is a unique leader in M&A advisory services for middle-market technology companies, and their venture capital investors, in the software, services, cleantech, biotech, and healthcare IT sectors. For additional information on DecisionPoint, visit: www.DecisionPointINT.com.
For further information, contact: Andy Agrawal, Managing Partner; (704) 943-5250; AAgrawal@DecisionPointINT.com.